Beam Therapeutics Inc.
BEAMFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Beam Therapeutics Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Vestmark Advisory Solutions, Inc. | 2026-03-31 | 176,865 | $4.21M | SEC filing |
| VOYA INVESTMENT MANAGEMENT LLC | 2026-03-31 | 41,493 | $989K | SEC filing |
| Pictet Asset Management Holding SA | 2026-03-31 | 297,504 | $6.54M | SEC filing |
| Allianz Asset Management GmbH | 2026-03-31 | 8,800 | $210K | SEC filing |
| Parkside Financial Bank & Trust | 2026-03-31 | 25 | $596 | SEC filing |
| Steward Partners Investment Advisory, LLC | 2026-03-31 | 1,350 | $32.2K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 700,647 | $16.7M | SEC filing |
| Leonteq Securities AG | 2026-03-31 | 12,367 | $295K | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 30,629 | $730K | SEC filing |
| CWM, LLC | 2026-03-31 | 4,364 | $104K | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 139,241 | $3.32M | SEC filing |
| Man Group plc | 2026-03-31 | 231,994 | $5.53M | SEC filing |
| C M BIDWELL & ASSOCIATES LTD | 2026-03-31 | 15 | $357 | SEC filing |
| TUDOR INVESTMENT CORP ET AL | 2026-03-31 | 47,310 | $1.13M | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 1,262 | $30.1K | SEC filing |
| Ishara Investments LP | 2026-03-31 | 57,400 | $1.37M | SEC filing |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 2026-03-31 | 8,791 | $209K | SEC filing |
| UBS Group AG | 2026-03-31 | 826,061 | $19.7M | SEC filing |
| HEADINVEST, LLC | 2026-03-31 | 20,060 | $478K | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 538,290 | $12.8M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Beam Therapeutics Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-26 · FMR LLC: Larger than 92 of the 93 other insider sales of Common Stock on file. SEC filing
- 2025-07-30 · FMR LLC: Larger than 84 of the 93 other insider sales of Common Stock on file. SEC filing
- 2024-11-06 · Ciaramella Giuseppe: Larger than 85 of the 93 other insider sales of Common Stock on file. SEC filing
- 2024-10-14 · Ciaramella Giuseppe: Larger than 85 of the 93 other insider sales of Common Stock on file. SEC filing
- 2024-09-30 · Evans John M.: Larger than 87 of the 93 other insider sales of Common Stock on file. SEC filing
- 2024-06-27 · Evans John M.: Larger than 87 of the 93 other insider sales of Common Stock on file. SEC filing
- 2024-03-28 · Evans John M.: Larger than 87 of the 93 other insider sales of Common Stock on file. SEC filing
- 2024-02-14 · FMR LLC: Larger than all 93 other insider sales of Common Stock on file. SEC filing
- 2024-01-31 · Evans John M.: Larger than 87 of the 93 other insider sales of Common Stock on file. SEC filing
- 2023-07-21 · Ciaramella Giuseppe: Larger than 91 of the 93 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-26 | FMR LLC · 10% owner, other | Common Stock | S — Open market or private sale | −251,488 | 35.26 | SEC filing |
| 2026-06-25 | FMR LLC · 10% owner, other | Common Stock | S — Open market or private sale | −33,372 | 35.12 | SEC filing |
| 2026-04-01 | Simon Amy · Chief Medical Officer | Common Stock | S — Open market or private sale | −6,700 | 24.58 | SEC filing |
| 2026-04-01 | Evans John M. · CEO | Common Stock | S — Open market or private sale | −30,078 | 24.58 | SEC filing |
| 2026-04-01 | Ciaramella Giuseppe · President | Common Stock | S — Open market or private sale | −11,810 | 24.58 | SEC filing |
| 2026-04-01 | Bellon Christine · Chief Legal Officer | Common Stock | S — Open market or private sale | −5,956 | 24.58 | SEC filing |
| 2026-04-01 | Cavanagh Bethany J · SVP, Finance and Treasurer | Common Stock | S — Open market or private sale | −3,242 | 24.58 | SEC filing |
| 2026-03-31 | Evans John M. · CEO | Common Stock | S — Open market or private sale | −25,000 | 22.76 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2033-06-06 | Walsh Kathleen E · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,532 | SEC filing |
| 2026-06-17 | Ciaramella Giuseppe · President | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −29,000 | SEC filing |
| 2026-06-17 | Ciaramella Giuseppe · President | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −6,505 | SEC filing |
| 2026-06-17 | Ciaramella Giuseppe · President | Common Stock | M — Exercise or conversion of derivative security | +29,000 | SEC filing |
| 2026-06-17 | Ciaramella Giuseppe · President | Common Stock | M — Exercise or conversion of derivative security | +6,505 | SEC filing |
| 2026-06-03 | COOPER GRAHAM K · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +19,676 | SEC filing |
| 2026-06-03 | Guindo Chirfi · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +19,676 | SEC filing |
| 2026-06-03 | MARAGANORE JOHN · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +19,676 | SEC filing |
Showing 8 of 21 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-12-22 | FMR LLC · 10% owner, other | Common Stock | J — Other acquisition or disposition | −29,549 | SEC filing |
| 2023-03-06 | Evans John M. · CEO | Common Stock | L — Small acquisition | +225 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.